Solara Active Pharma Sciences Share Price

    NSE
    634.3
    -2.35 (0.31%)
    SOLARA • 04 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    13.70%

    3Y Annualised Return

    26.33%

    5Y Annualised Return

    1.47%

    The current prices are delayed, login or Open Demat Account for live prices.

    Solara Active Pharma Sciences Stock Performance

    1W Return3.09
    1Y Return13.72
    Today's Low631.1
    Prev. Close636.65
    Mkt Cap (Cr.)2,834.05
    1M Return34.42
    3Y Return99.76
    52-Week High882.8
    Open633.25
    PE Ratio0.00
    6M Return-8.68
    Today's High649.3
    52-Week Low442.8
    Face Value10

    Solara Active Pharma Sciences Company background

    Founded in: 2017
    Managing director: Sandeep Rao
    Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two RD Centres in Chennai and Bengaluru. The Company offer rich basket of niche highvalue products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, antimalarias, antiinfective, neuromuscular insomnia and antipsychotic hyperkalemia segments, among others. It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches. Apart from this, the Solara Active has two research and development units in Bengaluru and Chennai equipped with stateoftheart facilities and a pipeline of 25+ products, at different stages of development. These drugs primarily deal with anthelmintic, antimalarias, beta blockers, muscle relaxants, novel oral anticoagulants, antiinfective and other niche segments.The Companys manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA) European Directorate for the Quality of Medicines (EDQM) Korea Food Drug Administration (KFDA) South Korea Euro Zone Good Manufacturing Practice (EUGMP) Danish, World Health Organization (WHO) Geneva Medicines and Healthcare products Regulatory Agency (MHRA) Federal Commission for the Protection against Sanitary Risk (Cofepris) Mexico Therapeutic Goods Administration (TGA) Australia Pharmaceuticals and Medical Devices Agency (PMDA) Japan.The Company acquired 100% of the equity shares of Strides Chemicals Private Limited and made it the wholly owned subsidiary of the Company effective from September 1, 2018. During the year 201819, the Companys wholly owned subsidiary Strides Chemicals Private Limited amalgamated with the Company on December 20, 2019 and the merger was given effect in February, 2020. The Companys new Greenfield plant situated at SEZ unit, Plot No.:3B,3C,3D, Part 2 and 2A1, APIIC APSEZ, Atchutapuram Village, Rambilli Mandal, Visakhapatnam 531011, Andhra Pradesh, commenced commercial production in 2021.The Company acquired 487000 additional stake in Sequent Penems Private Limited, subsidiary company and subsequently Sequent Pharma became the wholly owned subsidiary of Company effective from April 27, 2021. In 2024, the Company sold its entire shareholding in Sequent Penems Private Limited to Symbio Generrics India Private Limited and Sequent Penems Private Limited ceased to be asubsidiary of the Company with effect from April 25, 2024..

    As of 04 Jul, 2025, Solara Active Pharma Sciences share price is ₹636.8. The stock opened at ₹633.2 and had closed at ₹636.6 the previous day. During today’s trading session, Solara Active Pharma Sciences share price moved between ₹631.10 and ₹649.30, with an average price for the day of ₹640.20. Over the last 52 weeks, the stock has recorded a low of ₹442.80 and a high of ₹882.80. In terms of performance, Solara Active Pharma Sciences share price has declined by 8.7% over the past six months and has increased by 13.70% over the last year.

    Read More
    Solara Active Pharma Sciences SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹69,68,005 (+7.20%)

    Daily SIP of 25,000 would have become 69,68,005 in 1 year with a gain of 4,68,005 (+7.20%)

    View details of Market Depth

    Solara Active Pharma Sciences Fundamental

    Market Cap (in crs)

    2,834.05

    Face Value

    10

    Turnover (in lacs)

    592.91

    Key Metrics

    Qtr Change %
    27.87% Fall from 52W High
    24.2
    Dividend yield 1yr %
    0

    Solara Active Pharma Sciences Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Solara Active Pharma Sciences Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    273.01 Cr
    300.31 Cr
    346.95 Cr
    363.49 Cr
    299.43 Cr
    Solara Active Pharma Sciences Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    1292.08 Cr
    1294.29 Cr
    1466.36 Cr
    1288.36 Cr
    1645.65 Cr
    1349.27 Cr
    Solara Active Pharma Sciences Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    -2.1 Cr
    8.09 Cr
    8.01 Cr
    -13.46 Cr
    -255.45 Cr
    Solara Active Pharma Sciences Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    0.54 Cr
    -566.96 Cr
    -22.25 Cr
    -58.29 Cr
    221.35 Cr
    114.52 Cr

    Solara Active Pharma Sciences Result Highlights

    • Solara Active Pharma Sciences Ltd reported a 0.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 21.8%.

    • Its expenses for the quarter were up by 17.7% QoQ and down 9.1% YoY.

    • The net profit decreased 3254.9% QoQ and decreased 6888.0% YoY.

    • The earnings per share (EPS) of Solara Active Pharma Sciences Ltd declined at 70.9 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Solara Active Pharma Sciences

    Promoter
    37.9%
    Foreign Institutions
    14.6%
    Mutual Funds
    1.3%
    Domestic Institutions
    2.6%
    Public
    44.8%
    Promoter
    37.2%
    Foreign Institutions
    14.7%
    Mutual Funds
    1.3%
    Domestic Institutions
    3.2%
    Public
    44.9%
    Promoter
    37.3%
    Foreign Institutions
    14.2%
    Mutual Funds
    1.3%
    Domestic Institutions
    3.4%
    Public
    45.1%
    Promoter
    37.3%
    Foreign Institutions
    14%
    Mutual Funds
    1.3%
    Domestic Institutions
    2.8%
    Public
    45.9%
    Promoter
    30.5%
    Foreign Institutions
    15.8%
    Mutual Funds
    1.7%
    Domestic Institutions
    3%
    Public
    50.7%
    Promoter
    30.5%
    Foreign Institutions
    16.6%
    Mutual Funds
    1.7%
    Domestic Institutions
    1.8%
    Public
    51.1%

    Solara Active Pharma Sciences Technical Analysis

    Moving Averages Analysis
    634.3
    Current Price
    Bullish Moving Averages
    15
    Bearish Moving Averages
    1
    5Day EMA
    634.50
    10Day EMA
    614.30
    12Day EMA
    606.00
    20Day EMA
    579.70
    26Day EMA
    566.40
    50Day EMA
    542.30
    100Day EMA
    545.40
    200Day EMA
    561.00
    5Day SMA
    642.00
    10Day SMA
    616.80
    20Day SMA
    562.60
    30Day SMA
    534.40
    50Day SMA
    521.00
    100Day SMA
    513.00
    150Day SMA
    568.30
    200Day SMA
    619.70
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    57735 Rs
    112898 Rs
    Week Rs
    70859 Rs
    175316 Rs
    Month Rs
    118110 Rs
    415364 Rs
    639.07
    Pivot
    Resistance
    First Resistance
    647.03
    Second Resistance
    657.27
    Third Resistance
    665.23
    Support
    First Support
    628.83
    Second support
    620.87
    Third Support
    610.63
    Relative Strength Index
    74.05
    Money Flow Index
    90.63
    MACD
    39.58
    MACD Signal
    30.58
    Average True Range
    26.32
    Average Directional Index
    49.16
    Rate of Change (21)
    34.67
    Rate of Change (125)
    -9.09
    Name
    Holding Percent
    ADITYA BIRLA SUN LIFE TRUSTEE nPRIVATE LIMITED A/C ADITYA
    1.28
    THE SCOTTISH ORIENTAL SMALLER nCOMPANIES TRUSTPLC
    2.54
    HBM HEALTHCARE INVESTMENTS n(CAYMAN) LTD
    2.18
    FSSA INDIAN SUBCONTINENT FUND nAS SUB FUND OF FIRST SENTIER nINVESTORS GLOBAL UMBRELLA FUNDnPLC
    2.04
    CAISSE DE DEPOT ET PLACEMENT nDU QUEBEC - FIRST SENTIER nINVESTORS INTERNATIONAL IM nLIMITED
    1.92
    ROUTE ONE OFFSHORE MASTER nFUND
    1.45
    TURNAROUND OPPORTUNITIES FUND
    1.01

    Solara Active Pharma Sciences Latest News

    03 JUL 2025 | Thursday

    Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    02 JUL 2025 | Wednesday

    Solara Active Pharma Sciences Ltd - 541540 - Dispatch Of First Reminder Notice For Payment Of First Call Money

    01 JUL 2025 | Tuesday

    Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Credit Rating

    View More

    Solara Active Pharma Sciences Share Price FAQs

    Solara Active Pharma Sciences share price is ₹634.3 in NSE and ₹633.35 in BSE as on 4/7/2025.

    Solara Active Pharma Sciences share price in the past 1-year return was 13.72. The Solara Active Pharma Sciences share hit a 1-year low of Rs. 442.8 and a 1-year high of Rs. 882.8.

    The market cap of Solara Active Pharma Sciences is Rs. 2834.05 Cr. as of 4/7/2025.

    The PE ratios of Solara Active Pharma Sciences is 0 as of 4/7/2025.

    The PB ratios of Solara Active Pharma Sciences is 2.09 as of 4/7/2025

    The Mutual Fund Shareholding in Solara Active Pharma Sciences was 1.28% at the end of 4/7/2025.

    You can easily buy Solara Active Pharma Sciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Solara Active Pharma Sciences share price is ₹882.8 and ₹442.8 as of 4/7/2025.

    Please be aware that Solara Active Pharma Sciences stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.53
    +0.26 (+0.40%)
    139.24
    -0.46 (-0.33%)
    689.05
    -1.35 (-0.20%)
    2,599.10
    -12.10 (-0.46%)
    166.67
    -0.85 (-0.51%)
    391.40
    +0.75 (+0.19%)
    163.01
    -2.90 (-1.75%)
    261.40
    +0.55 (+0.21%)
    427.55
    +1.30 (+0.30%)
    401.00
    +1.10 (+0.28%)
    Top Gainers
    925.30
    +15.15 (+1.66%)
    1,640.70
    +22.00 (+1.36%)
    1,307.40
    +16.10 (+1.25%)
    1,442.80
    +16.90 (+1.19%)
    270.05
    +3.00 (+1.12%)
    Top Losers
    5,456.00
    -735.00 (-11.87%)
    163.01
    -2.90 (-1.75%)
    5,629.00
    -87.00 (-1.52%)
    1,655.20
    -16.70 (-1.00%)
    12,646.00
    -106.00 (-0.83%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -